Lrig1 anticorps
-
- Antigène Voir toutes Lrig1 Anticorps
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Lrig1 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein of human LRIG1 (NP_056356.2).
- Isotype
- IgG
- Top Product
- Discover our top product Lrig1 Anticorps primaire
-
-
- Indications d'application
- WB 1:1000-1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
- Autre désignation
- LRIG1 (Lrig1 Produits)
- Synonymes
- anticorps LIG-1, anticorps LIG1, anticorps D6Bwg0781e, anticorps Img, anticorps leucine rich repeats and immunoglobulin like domains 1, anticorps leucine-rich repeats and immunoglobulin-like domains 1, anticorps LRIG1, anticorps Lrig1
- Sujet
- Leucine-rich repeats and immunoglobulin-like domains protein 1is aproteinthat in humans is encoded by theLRIG1gene.It encodes atransmembrane proteinthat has been shown to interact with receptor tyrosine kinases of theEGFR-family,METandRET. Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
- Poids moléculaire
-
Observed_MW: 160kDa
Calculated_MW: 116kDa/119kDa
- ID gène
- 26018
- UniProt
- Q96JA1
-